Polypeptides for inducing a protective immune response against Staphylococcus aureus

Details for Australian Patent Application No. 2005214061 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Montgomery, Donna L.; Anderson, Annaliesa S.

Agent Spruson & Ferguson

Pub. Number AU-B-2005214061

PCT Pub. Number WO2005/079315

Priority 60/545,447 18.02.04 US

Filing date 14 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 4 February 2010

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/085 (2006.01) Medicinal preparations containing antigens or antibodies - Staphylococcus

C07K 14/31 (2006.01) Peptides having more than 20 amino acids

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/079315 Priority application(s): WO2005/079315

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 February 2010 Application Accepted

  Published as AU-B-2005214061

3 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214065-C10 cyclopentyl ester substituted taxanes

2005214043-Slotted pipe clamp with opposed flange engagement loops